Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Lauren Seeberger

Concepts (155)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Parkinson Disease
15
2024
614
1.720
Why?
Neurologic Examination
5
2024
129
1.180
Why?
Antiparkinson Agents
7
2015
41
1.120
Why?
Virtual Reality
1
2024
83
0.760
Why?
Huntington Disease
5
2025
60
0.680
Why?
Tai Ji
1
2020
4
0.650
Why?
Qigong
1
2020
2
0.650
Why?
Acupuncture Therapy
1
2020
20
0.630
Why?
Yoga
1
2020
32
0.630
Why?
Medical Marijuana
1
2020
120
0.560
Why?
Carbidopa
3
2015
10
0.550
Why?
Levodopa
4
2015
40
0.550
Why?
Tetrabenazine
1
2017
5
0.520
Why?
Vesicular Monoamine Transport Proteins
1
2017
9
0.520
Why?
Tardive Dyskinesia
1
2017
2
0.520
Why?
Valine
1
2017
84
0.500
Why?
Drug Therapy, Combination
4
2015
1036
0.410
Why?
Antipsychotic Agents
3
2017
185
0.390
Why?
Biological Availability
2
2009
146
0.320
Why?
Friedreich Ataxia
2
2022
77
0.320
Why?
Dyskinesia, Drug-Induced
1
2009
14
0.290
Why?
Clinical Trials as Topic
4
2022
1064
0.280
Why?
Torticollis
3
2005
21
0.280
Why?
Quinolones
1
2009
204
0.240
Why?
Piperazines
1
2009
368
0.230
Why?
Motor Skills
2
2025
103
0.220
Why?
Neurological Rehabilitation
1
2025
16
0.220
Why?
Music Therapy
1
2025
24
0.220
Why?
Movement
2
2024
290
0.220
Why?
Magnetoencephalography
1
2025
161
0.210
Why?
Eye Movements
1
2024
92
0.200
Why?
Hand
1
2024
157
0.190
Why?
Psychomotor Performance
1
2024
329
0.170
Why?
Cannabidiol
1
2024
142
0.170
Why?
Head Movements
1
2001
38
0.170
Why?
Dronabinol
1
2024
251
0.160
Why?
Patients
1
2002
183
0.150
Why?
Complementary Therapies
1
2020
93
0.150
Why?
Humans
29
2025
146342
0.150
Why?
Oxidoreductases
1
2019
91
0.140
Why?
Palliative Care
2
2024
1032
0.140
Why?
Scoliosis
1
2021
231
0.130
Why?
Treatment Outcome
7
2024
11821
0.120
Why?
Ubiquinone
1
2016
36
0.120
Why?
Health Status
1
2002
827
0.120
Why?
Caregivers
2
2024
1080
0.120
Why?
Observer Variation
3
2002
356
0.120
Why?
Suspensions
1
2015
28
0.120
Why?
Infusions, Parenteral
1
2015
47
0.120
Why?
Trinucleotide Repeat Expansion
1
2016
45
0.110
Why?
Adult
13
2025
41087
0.110
Why?
Vitamins
1
2016
183
0.110
Why?
Male
19
2025
73396
0.110
Why?
Immunoglobulin G
1
2019
901
0.110
Why?
Hypokinesia
2
2011
11
0.100
Why?
Telemedicine
1
2024
966
0.100
Why?
Nuclear Proteins
1
2019
740
0.100
Why?
Middle Aged
17
2025
36619
0.100
Why?
Genetic Association Studies
1
2016
379
0.100
Why?
Female
18
2025
79499
0.100
Why?
Cannabis
1
2020
521
0.100
Why?
Physicians
1
2002
955
0.090
Why?
Aged
13
2024
26432
0.090
Why?
Monoamine Oxidase Inhibitors
1
2011
20
0.090
Why?
Indans
1
2011
12
0.090
Why?
Autoantibodies
1
2019
1500
0.090
Why?
Motor Skills Disorders
1
2011
23
0.080
Why?
Dose-Response Relationship, Drug
4
2009
2022
0.080
Why?
Catechols
1
2009
14
0.070
Why?
Double-Blind Method
4
2024
2070
0.070
Why?
Randomized Controlled Trials as Topic
1
2016
1763
0.070
Why?
Aripiprazole
1
2009
18
0.070
Why?
Mental Disorders
1
2017
1148
0.070
Why?
Nitriles
1
2009
212
0.070
Why?
Botulinum Toxins, Type A
2
2005
60
0.060
Why?
Anti-Dyskinesia Agents
1
2005
8
0.050
Why?
Proof of Concept Study
1
2025
90
0.050
Why?
Follow-Up Studies
4
2009
5439
0.050
Why?
Time
1
2005
85
0.050
Why?
Neuromuscular Agents
1
2005
46
0.050
Why?
Basal Ganglia
1
2004
60
0.050
Why?
Botulinum Toxins
1
2005
49
0.050
Why?
Activities of Daily Living
2
2022
442
0.050
Why?
Neurologists
1
2024
22
0.050
Why?
Neuropsychological Tests
2
2007
1149
0.050
Why?
Young Adult
3
2021
14330
0.050
Why?
Dopamine
1
2004
295
0.040
Why?
Multiple Sclerosis
1
2007
435
0.040
Why?
Disability Evaluation
3
2011
297
0.040
Why?
Reference Standards
1
2001
176
0.040
Why?
Quality of Life
2
2024
3200
0.040
Why?
Prospective Studies
4
2019
8123
0.040
Why?
Longitudinal Studies
2
2021
3017
0.040
Why?
Acetamides
1
2001
42
0.040
Why?
Recovery of Function
1
2025
725
0.040
Why?
Feasibility Studies
1
2025
1135
0.040
Why?
Learning
1
2004
446
0.040
Why?
Dyskinesias
1
2000
20
0.040
Why?
Stiff-Person Syndrome
1
2019
14
0.040
Why?
Medical Records
1
2000
193
0.040
Why?
Age of Onset
1
2021
558
0.040
Why?
Reproducibility of Results
2
2011
3416
0.040
Why?
Severity of Illness Index
2
2011
2921
0.040
Why?
Range of Motion, Articular
1
2001
446
0.040
Why?
Glutamate Decarboxylase
1
2019
166
0.040
Why?
Clozapine
1
1998
20
0.030
Why?
Syndrome
1
2019
380
0.030
Why?
Retrospective Studies
4
2016
17438
0.030
Why?
Neurocognitive Disorders
1
1998
34
0.030
Why?
Walking
1
2022
546
0.030
Why?
Research Design
1
2022
1143
0.030
Why?
Muscle Spasticity
1
1996
63
0.030
Why?
International Cooperation
1
2016
193
0.030
Why?
Cognition
1
2004
1292
0.030
Why?
Australia
1
2016
291
0.030
Why?
Qualitative Research
1
2024
1734
0.030
Why?
Cerebrovascular Disorders
1
1996
103
0.030
Why?
Canada
1
2016
432
0.030
Why?
Single-Blind Method
1
2016
313
0.030
Why?
Predictive Value of Tests
1
2000
2113
0.030
Why?
Brain
1
2007
2991
0.030
Why?
Patient Care Team
1
2000
701
0.030
Why?
Prevalence
1
2021
2861
0.030
Why?
Disease Progression
1
2021
2867
0.020
Why?
Proportional Hazards Models
1
2016
1331
0.020
Why?
Aged, 80 and over
3
2011
8391
0.020
Why?
Time Factors
3
2011
7109
0.020
Why?
Adolescent
2
2021
22557
0.020
Why?
Education
1
2007
103
0.020
Why?
Verbal Learning
1
2007
75
0.020
Why?
Association Learning
1
2007
69
0.010
Why?
Drug Evaluation
1
2005
78
0.010
Why?
Cohort Studies
1
2016
6077
0.010
Why?
Matched-Pair Analysis
1
2004
38
0.010
Why?
Animals
1
2007
38107
0.010
Why?
Feedback, Psychological
1
2004
23
0.010
Why?
Mutation
1
2016
4093
0.010
Why?
Drug Resistance
1
2005
145
0.010
Why?
United States
2
2016
16136
0.010
Why?
Antibody Formation
1
2005
290
0.010
Why?
Probability
1
2004
309
0.010
Why?
Frontal Lobe
1
2004
159
0.010
Why?
Pain Measurement
1
2005
573
0.010
Why?
Models, Neurological
1
2004
252
0.010
Why?
Receptors, Glutamate
1
2001
27
0.010
Why?
Sex Characteristics
1
2007
801
0.010
Why?
Child
1
2021
22693
0.010
Why?
Patient Satisfaction
1
2005
706
0.010
Why?
Computer Simulation
1
2004
1014
0.010
Why?
Multicenter Studies as Topic
1
2001
417
0.010
Why?
Patient Compliance
1
2001
589
0.010
Why?
Patient Admission
1
1998
216
0.010
Why?
Aging
1
2007
1996
0.010
Why?
Ambulatory Care
1
1998
628
0.010
Why?
Risk Factors
1
2005
10921
0.000
Why?
Seeberger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)